NCT01918930 - Tissue Procurement Substudy for Participants in Study CP-MGA271-01 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

October 31, 2016

Study Completion Date

October 31, 2016

Conditions

Melanoma

Interventions

BIOLOGICAL

MGA271

MGA271 anti-B7-H3 monoclonal antibody

Trial Locations (7)

Hospital of the University of Pennsylvania/Abramson Cancer Center, Philadelphia

Carolina BioOncology Institute, Huntersville

Moffitt Cancer Center, Tampa

Sarah Cannon Research Institute, Nashville

The University of Chicago, Chicago

UCLA Hematology-Oncology Clinic, Los Angeles

Massachusetts General Hospital Cancer Center, Boston